Labeling of autologous monocytes with 99mTc-HMPAO at very high specific radioactivity

Nuclear Medicine and Biology

Volumn 34, Issue 8, 2007, Pages 933-938

  van Hemert, Formijn J ^a   Thurlings, Rogier ^a   Dohmen, Serge E ^a,b   Voermans, Carlijn ^a,b   Tak, Paul P ^a   van Eck Smit, Berthe L F ^a   Bennink, Roelof J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b SANQUIN RESEARCH   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; RVG 16226; UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; ARTICLE; BLOOD; CELL FUNCTION; CELL ISOLATION; CELL LABELING; CELL MEMBRANE; CELL POPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOLOGY; DRUG DECOMPOSITION; DRUG DISTRIBUTION; HUMAN; HUMAN CELL; HYDROPHILICITY; HYDROPHOBICITY; ISOTOPE LABELING; LEUKOCYTE; LIPOPHILICITY; LYMPHOCYTE; MONOCYTE; RADIOACTIVITY; RHEUMATOID ARTHRITIS; SCINTIGRAPHY;

ARTHRITIS, RHEUMATOID; CELLS, CULTURED; HUMANS; ISOTOPE LABELING; MONOCYTES; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M EXAMETAZIME;

EID: 35848970544     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2007.07.008     Document Type: Article

References (19)

1. Tak P.P. Chemokine inhibition in inflammatory arthritis. Best Pract Res Clin Rheumatol 20 (2006) 929-939
2. Tak P.P. Effects of infliximab treatment on rheumatoid synovial tissue. J Rheumatol Suppl 74 (2005) 31-34
3. Roca M., Martin-Comin J., Becker W., Bernardo-Filho M., Gutfilen B., Moisan A., et al. A consensus protocol for white blood cells labelling with technetium-99m hexamethylpropylene amine oxime. International Society of Radiolabeled Blood Elements (ISORBE). Eur J Nucl Med 25 (1998) 797-799
4. Palestro C.J. In vivo leukocyte labeling: the quest continues. J Nucl Med 48 (2007) 332-334
5. Becker W., Borst U., Krahe T., and Borner W. Tc-99m-HMPAO labelled human platelets: in vitro and in vivo results. Eur J Nucl Med 15 (1989) 296-301
6. Silistreli E., Bekis R., Serbest O., Arslan G., Ulker O., Catalyurek H., et al. Platelet scintigraphy results of heparin versus streptokinase treatment in acute deep vein thrombosis. Scand Cardiovasc J 38 (2004) 380-382
7. Jorgensen C., Couret I., Bologna C., Rossi M., and Sany J. Radiolabelled lymphocyte migration in rheumatoid synovitis. Ann Rheum Dis 54 (1995) 39-44
8. Fulgenzi A., Casati R., Colombo F.R., Gasparini M., Ferrero E., Bondanza A., et al. Distribution of 99mTc-labeled lymphocytes in control and inflamed rats. Nucl Med Biol 31 (2004) 631-638
9. Ridolfi R., Riccobon A., Galassi R., Giorgetti G., Petrini M., Fiammenghi L., et al. Evaluation of in vivo labelled dendritic cell migration in cancer patients. J Transl Med 2 (2004) 27
10. Fernandez P., Bordenave L., Celerier C., Bareille R., Brouillaud B., and Basse-Cathalinat B. A novel potential application for 99mTc-HMPAO: endothelial cell labeling for in vitro investigation of cell-biomaterial interactions. J Nucl Med 40 (1999) 1756-1763
11. Goins B., Klipper R., Rudolph A.S., and Phillips W.T. Use of technetium-99m-liposomes in tumor imaging. J Nucl Med 35 (1994) 1491-1498
12. Bockisch A. Sperm cell dynamics in the female rabbit genital tract after insemination monitored by radiolabeled spermatozoa. J Nucl Med 34 (1993) 1134-1139
13. Kadanali S., Varoglu E., Komec D., and Uslu H. Evaluation of active and passive transport mechanisms in genital tracts of IUD-bearing women with radionuclide hysterosalpingoscintigraphy. Contraception 63 (2001) 41-45
14. van Hemert F.J., van Lenthe H., Schimmel K.J., and Eck-Smit B.L. Preparation, radiochemical purity control and stability of 99mTc-mertiatide (Mag-3). Ann Nucl Med 19 (2005) 345-349
15. Verbruggen A.M. Lipophilic tracers for the study of regional cerebral blood flow. In: Ell P.J., and Gambhir S.S. (Eds). Nuclear medicine in clinical diagnosis and treatment (2004), Churchill Livingstone, Edinburgh 1257-1274
16. Kuppen P.J., Marinelli A., Camps J.A., Pauwels E.K., Van De Velde C.J., Fleuren G.J., et al. Biodistribution of lymphokine-activated killer (LAK) cells in Wag rats after hepatic-artery or jugular-vein infusion. Int J Cancer 52 (1992) 266-270
17. Mang'era K.O., Vanbilloen H.P., Schiepers C.W., and Verbruggen A.M. Stabilisation of high-activity 99mTc-d,l-HMPAO preparations with cobalt chloride and their biological behaviour. Eur J Nucl Med 22 (1995) 1163-1172
18. Jacquier-Sarlin M.R., Polla B.S., and Slosman D.O. Oxido-reductive state: the major determinant for cellular retention of technetium-99m-HMPAO. J Nucl Med 37 (1996) 1413-1416
19. Babich J.W. Technetium-99m-HMPAO retention and the role of glutathione: the debate continues. J Nucl Med 32 (1991) 1681-1683